[go: up one dir, main page]

MXPA94008605A - Viral vector with bovine viral diarrhea virus (bvdv) antigens. - Google Patents

Viral vector with bovine viral diarrhea virus (bvdv) antigens.

Info

Publication number
MXPA94008605A
MXPA94008605A MXPA94008605A MX9408605A MXPA94008605A MX PA94008605 A MXPA94008605 A MX PA94008605A MX PA94008605 A MXPA94008605 A MX PA94008605A MX 9408605 A MX9408605 A MX 9408605A MX PA94008605 A MXPA94008605 A MX PA94008605A
Authority
MX
Mexico
Prior art keywords
bvdv
antigens
diarrhea virus
virus
bovine
Prior art date
Application number
MXPA94008605A
Other languages
Spanish (es)
Inventor
C Wardley Richard
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of MXPA94008605A publication Critical patent/MXPA94008605A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
    • C12N2710/16641—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16643—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24311—Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

This invention relates to the field of Bovine Viral Diarrhea Virus (BVDV), and vaccines for the treatment thereof. This invention describes the preparation of live, attenuated Bovine Herpesvirus type I (BHV-1) as a virus, vaccine and vector for expression of BVDV antigens. A BVDV cDNA clone containing sequences corresponding to glycoprotein gp53 is inserted into an inactivated BHV-1 virus.
MXPA94008605A 1993-11-05 1994-11-07 Viral vector with bovine viral diarrhea virus (bvdv) antigens. MXPA94008605A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14781093A 1993-11-05 1993-11-05

Publications (1)

Publication Number Publication Date
MXPA94008605A true MXPA94008605A (en) 2004-11-11

Family

ID=22522990

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA94008605A MXPA94008605A (en) 1993-11-05 1994-11-07 Viral vector with bovine viral diarrhea virus (bvdv) antigens.

Country Status (9)

Country Link
EP (1) EP0725831A1 (en)
JP (1) JPH09504435A (en)
KR (1) KR960705944A (en)
CN (1) CN1134175A (en)
AU (1) AU688819B2 (en)
CA (1) CA2172815A1 (en)
MX (1) MXPA94008605A (en)
NZ (1) NZ276234A (en)
WO (1) WO1995012682A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6060457A (en) * 1996-06-20 2000-05-09 Universite De Montreal DNA plasmid vaccine for immunization of animals against BVDV
RU2158306C2 (en) * 1999-01-19 2000-10-27 Институт экспериментальной ветеринарии Сибири и Дальнего Востока СО РАСХН Method of detection of cattle viral diarrhea virus (mucosa disease) using specific oligonucleotide primers in polymerase chain reaction
EP1026252A1 (en) * 1999-02-02 2000-08-09 Akzo Nobel N.V. Synthetic gene of bovine viral diarrhoea virus
EP1104676A1 (en) 1999-11-30 2001-06-06 Boehringer Ingelheim Vetmedica Gmbh Safe attenuated bovine viral diarrhea viruses for use in pregnant cows
KR100331176B1 (en) * 1999-12-15 2002-04-06 대한민국(관리청:특허청장, 승계청:국립수의과학검역원장) A diagnostic method of bovine viral diarrhea using recombination protein as an antigen
EP2365082A1 (en) * 2000-06-27 2011-09-14 Pfizer Animal Health S.A. BVDV virus-like particles
ATE533506T1 (en) 2002-08-26 2011-12-15 Pfizer Prod Inc VACCINE AGAINST REPRODUCTIVE AND RESPIRATORY SYNDROME IN CATTLES
BRPI0417225A (en) * 2003-12-05 2007-03-06 Becton Dickinson Co methods of enhancing the intradermal compartment immune response and compounds useful in said methods
KR101876535B1 (en) * 2012-06-14 2018-07-09 베트올 (주) Antibody for detecting of bovine viral diarrhea virus(bvdv), bvdv antigen detecting method and test kit using thereof
CA2907098A1 (en) 2013-03-15 2014-09-25 Zoetis Services Llc Cross-protection of bovines against b. trehalosi infection by a multi-valent vaccine
CN113913461A (en) * 2021-11-15 2022-01-11 贵州大学 Construction of E0-E2 Gene Recombinant Adenovirus Vaccine for Bovine Viral Diarrhea

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1237668A (en) * 1983-02-25 1988-06-07 Novagene Inc. Thymidine kinase-negative temperature resistant bovine herpes-virus-1 mutant as vaccine
GB8818415D0 (en) * 1988-08-03 1988-09-07 Animal Health Inst Vaccine
FR2693472B1 (en) * 1992-06-26 1994-12-23 Rhone Merieux Mutants of the infectious bovine rhinotracheitis virus, deleted in one of the genes of minor glycoproteins, vaccines prepared from these strains, production methods and methods of use.
SE9002060D0 (en) * 1990-06-08 1990-06-08 Statens Veterinaermedicinska A A METHOD OF DETECTING AN INFECTION CAUSED BY A SPECIFIC TYPE OF VIRUSES, PRIMERS, TESTS AND A TEST KIT

Also Published As

Publication number Publication date
AU688819B2 (en) 1998-03-19
NZ276234A (en) 1998-01-26
WO1995012682A3 (en) 1995-07-06
AU1042395A (en) 1995-05-23
KR960705944A (en) 1996-11-08
JPH09504435A (en) 1997-05-06
CA2172815A1 (en) 1995-05-11
EP0725831A1 (en) 1996-08-14
CN1134175A (en) 1996-10-23
WO1995012682A2 (en) 1995-05-11

Similar Documents

Publication Publication Date Title
CA2031164A1 (en) Recombinant herpesvirus of turkeys and live vector vaccines derived thereof
GR3019112T3 (en) Porcine reproductive respiratory syndrome vaccine and diagnostic.
PT1403375E (en) Recombinant live vaccine, using avian herpes virus as vector
DE3278344D1 (en) Stabilization of influenza virus vaccine
PL317874A1 (en) Polynucleotidic vaccine against papilloma viruses
NZ503039A (en) Recombinant porcine adenovirus vector
FR2686896B1 (en) MUTANT ATTENUE OF LISTERIA MONOCYTOGENES; RECOMBINANT STRAIN OF LISTERIA MONOCYTOGENES, USE AS HETEROLOGOUS VECTORS OF VACCINE ANTIGENS AND USE AS VACCINE OR DIAGNOSTIC COMPOSITION.
MX9604907A (en) Newcastle disease virus combination vaccine.
GR3035050T3 (en) Method of preparing a viral vector by homologous intermolecular recombination
AU1198697A (en) Stabilizers for live vaccines
ZA986084B (en) CTL epitopes from EBV
IL101780A (en) Recombinant avipox virus a culture of cells infected with this virus vaccines for poultry derived from this virus use of the virus as a vector and a transfer sequence for insertion into the virus
MXPA94008605A (en) Viral vector with bovine viral diarrhea virus (bvdv) antigens.
ZA826154B (en) Infectious bronchitis vaccines for poultry, process for the preparation of such vaccines, process for preventing infectious broachitis and infectious bronchitis virus strain
GR3035135T3 (en) Poultry vaccine containing infections bronchitis virus serotype 4/91.
IL130075A0 (en) A vaccine for eliciting an immune response to an antigen in an animal
EP0541692A4 (en) Herpes simplex virus vp16 vaccines
GB9417249D0 (en) A novel salt
TW340873B (en) Chicken anaemia agent vaccine
EP0236977A3 (en) Bovine virus diarrhea and hog cholera vaccines
CA2116355A1 (en) Infectious bovine rhinotracheitis virus mutants and vaccines
ES8800358A1 (en) Vaccinal polypeptides.
GB9818133D0 (en) Vaccine
EP0654089A4 (en) Recombinant equine herpesviruses.
SI0729509T1 (en) Vaccine against mumps containing a jeryl-lynn virus strain